EXABS-203-MCL Is It Time to Recognize the Biological Heterogeneity of Mantle Cell Lymphoma?

Andre Goy

doi:10.1016/S2152-2650(22)00678-4

EXABS-203-MCL Is It Time to Recognize the Biological Heterogeneity of Mantle Cell Lymphoma?

Andre Goy

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S94
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	22
DOIs	https://doi.org/10.1016/S2152-2650(22)00678-4
State	Published - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

MCL

Access to Document

10.1016/S2152-2650(22)00678-4

Cite this

@article{ec65579767a3490fb18f5de5f187f0d3,

title = "EXABS-203-MCL Is It Time to Recognize the Biological Heterogeneity of Mantle Cell Lymphoma?",

keywords = "MCL",

author = "Andre Goy",

year = "2022",

month = oct,

doi = "10.1016/S2152-2650(22)00678-4",

language = "English",

volume = "22",

pages = "S94",

journal = "Clinical Lymphoma, Myeloma and Leukemia",